Fang Yue, van Meurs Joyce B J, Bergink Arjan P, Hofman Albert, van Duijn Cornelia M, van Leeuwen Johannes P T M, Pols Huibert A P, Uitterlinden André G
Department of Internal Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands.
J Bone Miner Res. 2003 Sep;18(9):1632-41. doi: 10.1359/jbmr.2003.18.9.1632.
A Cdx-2 binding site polymorphism (G to A) in the promoter region of the human vitamin D receptor gene was reported. In an ecological study in eight ethnic groups and an association study in 2848 elderly whites, we found the A-allele to be associated with decreased fracture risk. Our findings expand previous similar findings in a Japanese study to whites and show a relationship with fracture risk of this functional polymorphism.
A single nucleotide polymorphism (SNP) within a binding site of the intestinal-specific transcription factor Cdx-2 in the promoter region of the human vitamin D receptor (VDR) gene was previously reported. It was found to modulate the transcription of the hVDR gene and to be associated with decreased bone mineral density in a small group of postmenopausal Japanese women. In this study, we investigated the relationship between the VDR Cdx-2 genotype and risk of fracture.
We first determined the location of this SNP in the VDR gene by sequencing analysis, and we developed an allele-specific multiplex polymerase chain reaction test to determine the Cdx-2 genotype. We then performed an ecological study in eight ethnic groups and an association analysis in a large epidemiological cohort of 2848 Dutch white men and women, > or = 55 years old.
The location of the G to A substitution was found in the promoter region of exon le (le-G-1739A) of the VDR gene. By comparing the frequency of the A-allele in eight different ethnic groups, we observed a negative correlation between prevalence of the A-allele and published hip fracture incidence rates in these ethnic groups (p = 0.006 for men and p = 0.02 for women), suggesting a protective effect of this allele on fracture risk. Subsequently, in the association study, the A-allele (population frequency 19%) was observed to have a protective effect on occurrence of osteoporotic fractures, especially for nonvertebral fracture in women (relative risk of AA versus GG genotype is 0.2; 95% CI, 0.05-0.8). This effect remained after adjustment for age, weight, and bone mineral density. We conclude that the A-allele of the VDR Cdx-2 polymorphism is present in whites, albeit at low frequency, and show a protective effect of this allele on risk of fracture.
有报道称人类维生素D受体基因启动子区域存在一个Cdx - 2结合位点多态性(G突变为A)。在一项对八个种族群体的生态学研究以及对2848名老年白人的关联研究中,我们发现A等位基因与骨折风险降低相关。我们的研究结果将之前日本一项研究中的类似发现扩展至白人,并揭示了这种功能性多态性与骨折风险之间的关系。
先前报道了人类维生素D受体(VDR)基因启动子区域内肠道特异性转录因子Cdx - 2结合位点的一个单核苷酸多态性(SNP)。在一小群绝经后日本女性中发现它可调节hVDR基因的转录,并与骨密度降低相关。在本研究中,我们调查了VDR Cdx - 2基因型与骨折风险之间的关系。
我们首先通过测序分析确定该SNP在VDR基因中的位置,并开发了一种等位基因特异性多重聚合酶链反应检测方法来确定Cdx - 2基因型。然后我们在八个种族群体中进行了生态学研究,并在一个由2848名年龄≥55岁的荷兰白人男性和女性组成的大型流行病学队列中进行了关联分析。
在VDR基因外显子1(1 - G - 1739A)的启动子区域发现了G到A的替换位置。通过比较八个不同种族群体中A等位基因的频率,我们观察到A等位基因的患病率与这些种族群体中已公布的髋部骨折发病率之间呈负相关(男性p = 0.006,女性p = 0.02),表明该等位基因对骨折风险具有保护作用。随后,在关联研究中,观察到A等位基因(群体频率19%)对骨质疏松性骨折的发生具有保护作用,尤其是对女性的非椎体骨折(AA基因型与GG基因型相比的相对风险为0.2;95%置信区间,0.05 - 0.8)。在对年龄、体重和骨密度进行调整后,这种效应仍然存在。我们得出结论,VDR Cdx - 2多态性的A等位基因在白人中存在,尽管频率较低,并且显示出该等位基因对骨折风险具有保护作用。